Moreover, EPO production has been identified in the stromal cells of hemangioblastomas, which could explain that the comparison of patients with and without tumor recurrence highlighted no significant difference regarding the pre- and postoperative hematocrit levels, in accordance with previous results [2]. The gene discussed is EPO; the disease is hemangioblastoma.